{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:19:08Z","timestamp":1790011148345,"version":"4.0.1"},"reference-count":69,"publisher":"American Society for Clinical Investigation","issue":"6","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["DK112282"],"award-info":[{"award-number":["DK112282"]}]},{"name":"NIH","award":["P20GM103527"],"award-info":[{"award-number":["P20GM103527"]}]},{"name":"NIH","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      Beige and brown adipose tissue (BAT) are associated with improved metabolic homeostasis. We recently reported that the \u03b2\n                      <jats:sub>3<\/jats:sub>\n                      -adrenergic receptor agonist mirabegron induced beige adipose tissue in obese insulin-resistant subjects, and this was accompanied by improved glucose metabolism. Here we evaluated pioglitazone treatment with a combination pioglitazone and mirabegron treatment and compared these with previously published data evaluating mirabegron treatment alone. Both drugs were used at FDA-approved dosages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We measured BAT by PET CT scans, measured beige adipose tissue by immunohistochemistry, and comprehensively characterized glucose and lipid homeostasis and insulin sensitivity by euglycemic clamp and oral glucose tolerance tests. Subcutaneous white adipose tissue, muscle fiber type composition and capillary density, lipotoxicity, and systemic inflammation were evaluated by immunohistochemistry, gene expression profiling, mass spectroscopy, and ELISAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Treatment with pioglitazone or the combination of pioglitazone and mirabegron increased beige adipose tissue protein marker expression and improved insulin sensitivity and glucose homeostasis, but neither treatment induced BAT in these obese subjects. When the magnitude of the responses to the treatments was evaluated, mirabegron was found to be the most effective at inducing beige adipose tissue. Although monotherapy with either mirabegron or pioglitazone induced adipose beiging, combination treatment resulted in less beiging than either alone. The 3 treatments also had different effects on muscle fiber type switching and capillary density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The addition of pioglitazone to mirabegron treatment does not enhance beiging or increase BAT in obese insulin-resistant research participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT02919176.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>NIH DK112282 and P20GM103527 and Clinical and Translational Science Awards grant UL1TR001998.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1172\/jci.insight.143650","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:06:19Z","timestamp":1613045179000},"source":"Crossref","is-referenced-by-count":19,"title":["Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism"],"prefix":"10.1172","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-1818","authenticated-orcid":true,"given":"Brian S.","family":"Finlin","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, College of Medicine,"},{"name":"Barnstable Brown Diabetes and Obesity Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasiyet","family":"Memetimin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, College of Medicine,"},{"name":"Barnstable Brown Diabetes and Obesity Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, College of Medicine,"},{"name":"Barnstable Brown Diabetes and Obesity Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Confides","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy and Center for Muscle Biology, College of Health Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-5235","authenticated-orcid":true,"given":"Hemendra J.","family":"Vekaria","sequence":"additional","affiliation":[{"name":"Spinal Cord and Brain Injury Research Center, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-491X","authenticated-orcid":true,"given":"Riham H.","family":"El Khouli","sequence":"additional","affiliation":[{"name":"Department of Radiology, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Westgate","sequence":"additional","affiliation":[{"name":"College of Public Health, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA."},{"name":"Lexington Veterans Affairs Medical Center, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-4865","authenticated-orcid":true,"given":"Andrew J.","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA."},{"name":"Lexington Veterans Affairs Medical Center, Lexington, Kentucky, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7418-4760","authenticated-orcid":true,"given":"Patrick G.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Spinal Cord and Brain Injury Research Center, College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5576-9659","authenticated-orcid":true,"given":"Esther E.","family":"Dupont-Versteegden","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy and Center for Muscle Biology, College of Health Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4761-7417","authenticated-orcid":true,"given":"Philip A.","family":"Kern","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, College of Medicine,"},{"name":"Barnstable Brown Diabetes and Obesity Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.04.011"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI88883"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.06.016"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021909-135846"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.017"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.09.007"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2019.07.001"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.016"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78362"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3361"},{"issue":"1\u20132","key":"B11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cell.2013.12.021","article-title":"Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch","volume":"156","author":"Cohen","year":"2014","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4031"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44271"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4429"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134892"},{"issue":"15","key":"B16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121510","article-title":"Human adipose beiging in response to cold and mirabegron","volume":"3","author":"Finlin","year":"2018","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68993"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.82"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67803"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1372"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3891"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.04.029"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0746"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20456"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2019.07.001"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705287114"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.06.011"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.04.006"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1057"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature13528"},{"issue":"5","key":"B31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.bbalip.2013.02.005","article-title":"White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma","volume":"1831","author":"Frontini","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.06.011"},{"issue":"2\u20133","key":"B33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(02)01421-8","article-title":"beta(3)-Adrenoceptor agonists: potential, pitfalls and progress","volume":"440","author":"Arch","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131126"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0462"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.12.009"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136476"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.47.29909"},{"issue":"2","key":"B39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbadis.2005.02.003","article-title":"PPARgamma in the control of brown adipocyte differentiation","volume":"1740","author":"Nedergaard","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.027"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.01.019"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.053942"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00249","article-title":"Rosiglitazone and a \u03b23-adrenoceptor agonist are both required for functional browning of white adipocytes in culture","volume":"9","author":"Merlin","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.09.023"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21752"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1392"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0000000000000017"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00345-0"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/BF01119774"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8567"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.47.29909"},{"issue":"suppl 3","key":"B52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"B53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020348","article-title":"Skeletal muscle fiber type: influence on contractile and metabolic properties","volume":"2","author":"Zierath","year":"2004","journal-title":"PLoS Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113088"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67166"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118124"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1637"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2017.04.012"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.10.002"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303360110"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.7.3057-3067.2004"},{"issue":"4","key":"B62","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz298","article-title":"Beta-1 and not beta-3 adrenergic receptors may be the primary regulator of human brown adipocyte metabolism","volume":"105","author":"Riis-Vestergaard","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.07.005"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12433"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-013-2042-x"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4479-9"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.50108"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.07.014"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.628487"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/143650\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:45:13Z","timestamp":1779151513000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/143650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,3,22]]}},"alternative-id":["10.1172\/jci.insight.143650"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.143650","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"article-number":"e143650"}}